Influence of a moderate exercise training on natural killer cytotoxicity and personality traits in cancer patients - PubMed (original) (raw)
. 1994 May-Jun;14(3A):1033-6.
Affiliations
- PMID: 8074446
Influence of a moderate exercise training on natural killer cytotoxicity and personality traits in cancer patients
C Peters et al. Anticancer Res. 1994 May-Jun.
Abstract
We have investigated the influence of exercise training on natural killer cells and psychological behaviour in cancer patients. 24 women with carcinomas of the breast performed a moderate training program two to three times a week for seven months. At the beginning, after five weeks and at the end of the study we analyzed the amount and the activity of natural killer cells (CD 56) under resting conditions. Personality traits were measured with the FPI-R questionnaire at the same time points. While the amount of natural killer cells did not change, their cytotoxic activity was increased at the end of the study. Furthermore, the discomfort decreased. After 5 weeks satisfaction of life was enhanced and at the end of the investigation we observed a strict connection of this improvement with the frequency of exercise. These results demonstrate a stimulating influence of moderate exercise training on the resting NK-cell activity even in cancer patients.
Similar articles
- Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients.
Nieman DC, Cook VD, Henson DA, Suttles J, Rejeski WJ, Ribisl PM, Fagoaga OR, Nehlsen-Cannarella SL. Nieman DC, et al. Int J Sports Med. 1995 Jul;16(5):334-7. doi: 10.1055/s-2007-973015. Int J Sports Med. 1995. PMID: 7558532 Clinical Trial. - [The effect of sera of breast cancer patients on NK cell activity].
Konjević G, Spuzić I. Konjević G, et al. Srp Arh Celok Lek. 1995 Sep-Oct;123(9-10):227-31. Srp Arh Celok Lek. 1995. PMID: 17974436 Serbian. - Reduction in resting plasma granulysin as a marker of increased training load.
Shing CM, Ogawa K, Zhang X, Nagatomi R, Peake JM, Suzuki K, Jenkins DG, Coombes JS. Shing CM, et al. Exerc Immunol Rev. 2007;13:89-99. Exerc Immunol Rev. 2007. PMID: 18198663 Review. - Exercise, cancer and the immune response of monocytes.
Peters C, Lötzerich H, Niemeir B, Schüle K, Uhlenbruck G. Peters C, et al. Anticancer Res. 1995 Jan-Feb;15(1):175-9. Anticancer Res. 1995. PMID: 7733630 - [Methodological approaches to the study of natural killer cells in clinical conditions (review of the literature)].
Shparik IaV, Bilynskiĭ BT. Shparik IaV, et al. Lab Delo. 1988;(5):3-7. Lab Delo. 1988. PMID: 2459448 Review. Russian. No abstract available.
Cited by
- Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia.
Pradhan R, Dieterich W, Natarajan A, Schwappacher R, Reljic D, Herrmann HJ, Neurath MF, Zopf Y. Pradhan R, et al. Cancers (Basel). 2024 May 18;16(10):1921. doi: 10.3390/cancers16101921. Cancers (Basel). 2024. PMID: 38791998 Free PMC article. Review. - Impact of physical activity and energy restriction on immune regulation of cancer.
Xu Y, Rogers CJ. Xu Y, et al. Transl Cancer Res. 2020 Sep;9(9):5700-5731. doi: 10.21037/tcr.2020.03.38. Transl Cancer Res. 2020. PMID: 35117934 Free PMC article. Review. - Physical Activity and Breast Cancer Prevention: Possible Role of Immune Mediators.
Xu Y, Rogers CJ. Xu Y, et al. Front Nutr. 2020 Oct 8;7:557997. doi: 10.3389/fnut.2020.557997. eCollection 2020. Front Nutr. 2020. PMID: 33134306 Free PMC article. Review. - Aerobic physical exercise for adult patients with haematological malignancies.
Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N. Knips L, et al. Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD009075. doi: 10.1002/14651858.CD009075.pub3. Cochrane Database Syst Rev. 2019. PMID: 30702150 Free PMC article. - Influence of physical activity on the immune system in breast cancer patients during chemotherapy.
Schmidt T, Jonat W, Wesch D, Oberg HH, Adam-Klages S, Keller L, Röcken C, Mundhenke C. Schmidt T, et al. J Cancer Res Clin Oncol. 2018 Mar;144(3):579-586. doi: 10.1007/s00432-017-2573-5. Epub 2018 Jan 5. J Cancer Res Clin Oncol. 2018. PMID: 29305709 Clinical Trial.